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11. INTRODUCTION
People have been using plants as a source of medicine since the beginning of human
Civilization. Perhaps as early as Neanderthal man, plants were believed to have
healing power (Anna, 1993). The traditional society across the world have always
used herbs to promote healing (Okoli., et al 2007).In today's world herbal medicine is
the most predominant means of healthcare in developing countries where about 80%
of their total population depends on it for their wellbeing (Akabue., 1982). Plants
form the basis of for the development of modern drugs and medicinal plants have
been used for many years to treat disease all throughout the world in the daily course
of life (W.H.O., 1991, Patil., 2011 and Hamid., 2011). Since a long, time plants have
represented the only source of therapeutical agents known to man. Plants have
become the primary source of substances for drug development (Zaroni et al., 2004).
This knowledge of plant based drugs developed gradually and was passed on this
laying the foundation for many systems of traditional medicine all over the world.
Folk medicine does strongly assent its faith in the therapeutic effectiveness of plant
preparations (Kumari et al., 2011). Herbs are mines of useful drugs, since ancient past
and presently they are becoming popular. Moreover the medicinal plant wealth is our
national heritage and it seems to be the first and foremost line of defence for the
treatment of various diseases mostly in the tribal and rural communities (Kaul and
Dwivedi., 2010).According to the WHO, over 80% of the world's population relies on
traditional forms of medicine, largely plant based to meet primary health care needs.
The medicinal plants are extensively utilized throughout the world in two distinct
areas of health management; traditional system of medicine and modern system of
medicine. The medicinal attributes of many plants are found in leaves, used as
alterative, tonic diuretic, blood purifier and antiphlogistic. They are used as remedy
against chronic eczema, chronic ulcer, chronic rheumatism, chronic nervous diseases,
madness, cholera, amenorrhea, piles and fistula. In terms of the number of species
individually targeted, the use of the plants as medicines represents by far the biggest
human use of the natural world. Plants provide the predominant ingredients of
medicines in most medical traditions (Mohd et al., 2009). Recent estimates suggests
that over 9000 plants have known
2medicinal applications in various cultures and countries, and this is without having
conducted comprehensive research amongst several indigenous and other
communities (Farnsworth .,1991). Medicinal plants are used at the household level by
women taking care of their families at the village level by medicine men or tribal
shamns , and by the practitioners of classical traditional systems of medicine such as
Ayurveda, Chinese medicine , or the Japanese kampo system.
According to the World Health Organisation, over 80% of the world’s population or
4.3 billion people rely upon such traditional plant based systems of medicine to
provide them with primary health care (Attiso., 1983). Medicinal plants are used to
treat illness and diseases for thousands of years. They have gained economic
importance because of their application in pharmaceutical, cosmetic, perfumery and
food industries. The interest in herbal systems of medicine is growing day-by-day
because nature can cure many diseases. Herbs are staging a comeback and herbal
‘renaissance’ is happening all over the globe. The herbal products today symbolise
safety in contrast to the synthetics that are regarded as unsafe to human and
environment. Although herbs had been priced for their medicinal, flavouring and
aromatic qualities for centuries, the synthetic products of the modern age surpassed
their importance, for a while. However, the blind dependence on synthetics is over
and people are returning to the naturals with hope of safety and security.
Over three-quarters of the world population relies mainly on plants and plant extracts
for health care. More than 30% of the entire plant species, at one time or other was
used for medicinal purposes. It is estimated that world market for plant derived drugs
may account for about Rs.2, 00,000 crores. Presently, Indian contribution is less than
Rs.2000 crores. Indian export of raw drugs has steadily grown at 26% to Rs.165
crores in 1994-’95 from Rs.130 crores in 1991-’92. The annual production of
medicinal and aromatic plant’s raw material is worth about Rs.200 crores. This is
likely to touch US $5 trillion by the year 2050.
It has been estimated that in developed countries such as United States, plant drugs
constitute as much as 25% of the total drugs, while in fast developing countries such
as China and India, the contribution is as much as 80%. Thus, the economic
importance of medicinal plants is much more to countries such as India than to rest of
the world. These countries provide two third of the plants used in modern system of
3medicine and the health care system of rural population depend on indigenous
systems of medicine.
Green plants synthesise and preserve a variety of biochemical products, many of
which are extractable and used as chemical feed stocks or as raw material for various
scientific investigations. Many secondary metabolites of plant are commercially
important and find use in a number of pharmaceutical compounds. However, a
sustained supply of the source material often becomes difficult due to the factors like
environmental changes, cultural practices, diverse geographical distribution, labour
cost, and selection of the superior plant stock and over exploitation by pharmaceutical
industry. Plants, especially used in Ayurveda can provide biologically active
molecules and lead structures for the development of modified derivatives with
enhanced activity and reduced toxicity. The small fraction of flowering plants that
have so far been investigated have yielded about 120 therapeutic agents of known
structure from about 90 species of plants (Joy et al.,).
Some of the useful plant drugs include vinblastine, vincristine, taxol,
podophyllotoxin, camptothecin, digitoxigenin, gitoxigenin, digoxigenin, tubocurarine,
morphine, codeine, atropine, pilocarpine, capscicine, allicin, curcumin, artemesinin
and ephedrine among others. In some cases, the crude extract of medicinal plants may
be used as medicaments. On the other hand, the isolation and identification of the
active principles and elucidation of the mechanism of action of a drug is of paramount
importance. Hence, works in both mixture of traditional medicine and single active
compounds are very important. Where the active molecule cannot be synthesised
economically, the product must be obtained from the cultivation of plant material
(Mukherjee & Mukhhetjee, 2005).
Major pharmaceutical companies are currently conducting extensive research on plant
materials gathered from the rain forests and other places for their potential medicinal
value. Interest in herbal medicines has continued to grow. This is shown in several
ways, for example, by increased retail sales of herbal medicinal products in Europe
and the USA as well as the greater awareness among the public and healthcare
professionals about natural health products and complementary therapies. Industrially
produced new herbal products, mainly based on single-herb extracts standardized for
its specific active ingredient, continue to be developed.
4In India knowledge of medicinal plant is very old, and medicinal properties of plants
are described in 3500-1500 B.C, from which Ayurveda developed.  In Ayurveda the
ancient well known treatise are Charak samhita dealing mostly with plants in sashrat
samhita in which surgery is also maintained. In Egypt the people were familiar with
medicinal properties of plants and animals. Greek scientists contributed much to the
knowledge of natural history.  Hippocraties (460-370 B.C) is referred to as father of
medicine and is remembered for his famous writings on kingdom, which is considered
authoritative even in the 20th century. The substances from the plants were isolated,
the structure was elucidated and the pharmacologically active constituents were
studied. In 1934-1960 simultaneous applications of disciplines developed like organic
chemistry, biochemistry, biosynthesis, pharmacology and modern methods and
techniques of medicinal chemistry including paper, thin layer chromatography, gas
chromatography and spectrophotometry.
Plants have provided the lead molecules for a large number of diseases. During the
past 40 years numerous novel compounds have been isolated from plant sources and
many of these substances have been demonstrated to possess interesting biological
activities. India is the treasure house of herbs and more than 9000 different herbs with
varying medicinal properties are present. Ayurveda an ancient system of Indian
medicine has recommended a number of drugs from indigenous plant and animal
sources for the treatment of several diseases and disorders. More than 13,000 plants
have been studied during the last 5 years (Trease and Evans; Shah & Qadry
1996; Varrote Tyler-iynn et al., 1996).
1.1. Herbal Medicines
Herbal Medicine sometimes referred to as Herbalism or Botanical Medicine, is the
use of herbs for their therapeutic or medicinal value. An herb is a plant or plant part
valued for its medicinal, aromatic or savory qualities. Herb plants contain a variety of
chemical substances that has therapeutic value.
Herbal Medicine is the oldest form of healthcare known to mankind. Herbs had been
used by all cultures throughout history. It was an integral part of the development of
modern civilization. Primitive man observed and appreciated the great diversity of
plants available to him. The plants provided food, clothing, shelter and medicine.
Much of the medicinal use of plants seems to have been developed through
5observations of wild animals and by trial and error. As time went on, each tribe added
the medicinal power of herbs in their area to its knowledge base. They methodically
collected information on herbs and developed well–defined herbal pharmacopoeias.
Indeed, well into the 20th century much of the pharmacopoeia of scientific medicine
was derived from the herbal lore of native peoples. Many drugs commonly used today
are of herbal origin. Indeed, about 25 % of the prescription drugs dispensed in the
United States contain at least one active ingredient derived from plant material. Some
are made from plant extracts; others are synthesized to mimic a natural plant
compound.
Major pharmaceutical companies are currently conducting extensive research on plant
materials gathered from the rain forests and other places for their potential medicinal
value (WHO, 1993).
1.2. Synthetic Drug: Dominance
Pharmaceutical research took a major leap when alongside natural plants chemistry,
pharmacologists, microbiologists and biochemists began to unravel the chemistry of
natural products in human beings, animals, plants and microorganisms. Advances in
synthetic organic chemistry led to the identification of many chemical molecules that
offered more opportunities to develop novel compounds. Many new drugs emerged
by this route, particularly those now being used to treat infections, infestations,
cancers, ulcers, heart and blood pressure conditions. Many drugs were developed
through random screening of thousands of chemicals synthesized as dye-stuffs and the
like; many others resulted from serendipity arising from sharp eyed observations of
physicians and scientists. Example of such drugs includes sulphonamides, isoniazid,
antipsychotics, antihistamines and penicillin. Emergence of the modern
pharmaceutical industry is an outcome of all these different activities that developed
potent single molecules with highly active for a wide variety of ailments. The drugs
produced in many cases improved on nature, a new range of local anesthetics from
cocaine avoided its dangerous effects on blood pressure, and chloroquine is much less
toxic than quinine. These successes and many more like them resulted in reduced
interest in natural products drug discovery and many major drug companies almost
neglected such divisions. Work on developing new drugs for the treatment of the
world’s major diseases such as malaria, trypanosomiasis, filariasis, tuberculosis,
6schistosomiasis, leshmaniasis and amoebiasis came almost to a standstill. In addition,
although botanical medications continued to be produced in every country, the clinical
efficacy of these was usually not evaluated and the composition of these complex
mixtures was only crudely analyzed. Thus herbal medicines became the domain of
‘old wives tales’ and quack medicine, exploitation of the sick, the desperate and the
gullible. Sadly, herbal medicines continued to reflect poor quality control both for
materials and clinical efficacy (Patwardhan et al.,)
1.3. Development of Phytomedicines for various diseases
Medicinal plants play a key role in the human health care. About 80% of the world
population relies on the use of traditional medicine, which is predominantly based on
plant materials (WHO, 1993). The traditional medicine refers to a broad range of
ancient natural health care practices including folk tribal practices as well as
Ayurveda, Siddha, Amchi and Unani. These medical practices originated from time
immemorial and developed gradually, to a large extent, by relying or based on
practical experiences without significant references to modern scientific principles.
These practices incorporated ancient beliefs and were passed on from one generation
to another by oral tradition and guarded literature. Although herbal medicines are
effective in the treatment of various ailments very often these drugs are
unscientifically exploited and improperly used. Therefore, these plant drugs deserve
detailed studies in the light of modern science.
1.4. Phytotherapeutic Approach of Drug Development
In phytotherapeutic approach, the emphasis is on the development of a new drug
whose extraction and fractionation have emanated on the basis of therapeutic activity.
The standard fraction of an active extract or mixture of fractions may prove better
therapeutically, less toxic and inexpensive compared to pure isolated compound
drugs. However, crude plant preparations require modern standards of safety and
efficacy. Modern bioassay methods and physiochemical profile do provide ways and
means of developing quality control as well as determining the expiry date of crude
preparations or fractions. Standardized herbal preparations may serve as inexpensive
and useful drugs to the masses.
Herbal drugs have gained importance in recent years because of their efficacy and
cost effectiveness. These drugs are invariably single plant extracts or fractions thereof
7or mixtures of fractions of extracts from different plants which have been carefully
standardized for their safety and efficacy (Suck Dev 1997).
1.5. Traditional Wisdom
Lag phase for botanical medicine is now rapidly changing for a number of reasons.
Problems with drug resistant microorganisms, side effects of modern drugs, and
emerging diseases where no medicines are available, have stimulated renewed interest
in plants as a significant source of new medicines. Pharmaceutical scientists are
experiencing difficulty in identifying new lead structures, templates and scaffolds in
the finite world of chemical diversity. A number of synthetic drugs have adverse and
unacceptable side effects. There have been impressive successes with botanical
medicines, most notably quinghaosu, artemisinin from Chinese medicine.
Considerable research on Pharmacognosy, Chemistry, Pharmacology and Clinical
therapeutics has been carried out on Ayurvedic medicinal plants. Numerous
molecules have come out of Ayurvedic experimental base, examples include Rawolfia
alkaloids for hypertension, psoriases in vitiligo, hypolipidemic agents, mucana
pruriens for Parkinson’s disease, piperidines as bioavailability enhancers, baccosides
in mental retention, pierosides in hepatic protection, phyllanthins as antivirals,
curcumine in inflammation and many other steroidal lactones and glycosides as
immunomodulators. A whole range of chronic and difficult to treat diseases such as
cancers, cardiovascular diseases, diabetes, rheumatism and AIDS all require new
effective drugs. Most developing countries have relied and will continue to rely on
traditional natural medicines due to the deterrence of high costs of modern allopathic
medicines (Patwardhan et al.,)
Current estimation indicates that about 80% of people in developing countries still
rely on traditional medicine based largely on various species of plants and animals for
their primary healthcare. Four out of ten Americans used alternative medicine
therapies in 1997. Total visits to alternative medicine practitioners increased by
almost 50 from 1990 and exceeded the visits to all US primary care physicians (Suck
Dev 1997).
1.6. Cancer
Cancer is a general term applied to a series of malignant diseases which may affects
many different parts of the body. These diseases are characterized by rapid and
8uncontrolled formation of abnormal cells which may mass together to form a growth
or tumour, or proliferate throughout the body. Initiating abnormal growth at other
sites, if the process is not arrested, it may progress until it causes the death of the
organism. Cancer is commonly encountered in all higher animals, and plants also
develop growth that resembles cancer. Next to heart disease, cancer is a major killer
of mankind. Cancer is basically a disease of cells characterized by the loss of normal
cellular growth, maturation and multiplication, and thus homeostasis is disturbed.
Carcinogens
Carcinogens, the agents that cause cancer, have been classified into three broad
groups' viz physical, chemical and biological.
Physical agents
Ultraviolet and ionizing radiations are mutagenic and carcinogenic, which may
damage DNA in several ways. Ultraviolet radiation catalyzes the formation of
covalent pyrimidine dimer, thus distorting the A-T, C-G bases pairing sequence in
DNA strand. Ionizing radiation (X-rays, G-rays) can break the backbone of DNA
molecule either by altering the base sequences structurally or by deletion of the bases
from the backbone. Apart from direct effects on DNA, X-rays and G-rays cause free
radicals to form in the tissues which can lead to oxidative DNA damage.
Chemical agents
It is estimated that 80% of human cancers are due to environmental factors,
principally chemicals. A variety of compounds viz., polycyclic aromatic
hydrocarbons, nitrosamines, alkylating agents and other inorganic and naturally
occurring compounds are carcinogenic. Generally all carcinogens are electrophiles
which attack nucleophilic groups in the DNA and RNA and proteins and thus damage
the cell.
Many of the alkylating agents can act directly on the target molecules (direct
carcinogens) but there are other compounds, which cannot act directly and require
prior metabolism to become carcinogens (procarcinogens). Thus chemical
carcinogens can be classified as
 Initiating agent – which is capable of initiating cells only.
9 Promoting agent – capable of causing the expression of initiated cell clones.
 Progressor agent – which can convert initiated cell or a cell in the stage of
promotion to a potentially malignant cell.
 A complete carcinogen has all the properties of initiating, promoting and
progressor agents.
Another potential source of exogenous transforming mutations are certain
biochemical processes which generate significant quantities of reactive oxygen
species (ROS) and free radicals that are estimated to cause alterations in the DNA.
Therefore, processes inherent in the cell and not necessarily dependent on exposure to
exogenous agents may cause carcinogenesis. But it must be emphasized that
environmental carcinogens significantly increase the risk of cancer and carcinogens
do accelerate the process of carcinogenesis. The interaction of an “ultimate”
carcinogen (i.e. the active electrophile) with DNA targets determines the formation
and permanent fixation of transforming lesions.
Biological agents
The oncogenic viruses are well known and form a very diverse group of carcinogenic
agents. They include members of all major families of DNA viruses that infect
vertebrates except very small Parvovirus’s and the very large Poxviruses. On the other
hand, only one family of RNA viruses, the retroviruses, can cause tumors. The tumor
viruses vary in complexity of their genomes, in the types of neoplasm they induce and
in their requirement for co-factors in tumor genesis. RNA tumor viruses are
characterized by the presence of RNA-dependant DNA polymerase (reverse
transcriptase). Once the virus core enters the cell, the reverse transcriptase transcribes
the single stranded RNA viral genome into double stranded DNA copies. The original
viral RNA becomes degraded and the viral DNA copy (provirus) is then inserted
(integrated) by a covalent linkage into the host cell DNA.
Endogenous DNA damage from normal oxidation is enormous. The steady state of
oxidative damage in DNA is about one million oxidative lesions per rat cell. This high
background suggests that increasing the cell division rate must be a factor in
converting lesions to mutations and thus cancer. Raising the level of either DNA
lesions or cell division will increase the probability of cancer. Just as DNA repair
protects against lesions, guards the cell cycle and protects against cell division if the
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lesion level gets too high. If the lesion level becomes still higher, can initiate
programmed cell death (apoptosis).
1.7 Main Features of Cancer
 Excessive cell growth, usually in the form of tumor.
 Invasiveness, i. e. the ability to grow into surrounding    tissue.
 Undifferentiated cells or tissue.
 The ability to metastasize or spread to new sites and establish new growth;
 A type of acquired heredity in which the progeny of cancer cells also retain
cancerous property.
 A shift of cellular metabolism towards increase in production of macromolecules
from nucleosides and amino acids, with an increased catabolism of carbohydrates
for cellular energy. Such behavior of cancer cells lead to illness in the host as a
result of
 Pressure effect due to local tumor growth;
 Destruction of the organ involved by the primary growth;
 Systemic effect as a result of new growth.
1.8 Causes of Cancer
Many factors are implicated in the causation of cancer. These factors are listed as
 Exposure to the carcinogenic hydrocarbons or to excessive radiation.
 Hereditary factors: A “cancer family syndrome” has been described by the
Lynch et al., The hereditary factors involved in the causation of cancer are
chromosomal abnormality, enzymes, immune defense system, hormonal
imbalance etc.
 Cultural factors: cultural factor play a dominant role by causing about 70 % of
all cancers. The important amongst are diet, smoking, drinking and sexual
habits.
 Occupational factors: These factors are ionizing radiation, chemicals and other
substances for example- coal tar, mustard gas, chromium, hematite, nickel and
asbestos can trigger lung cancer in employees working in chemical, insulation
and gas factories.
 Viruses: Though it is known that viruses cause cancer in animals, their role in
human cancer has not been proved.
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1.9 Cell Cycle
Cellular multiplication involves passage of cell through a cell cycle. The
various phases of cell cycle are characterized as:
 The interval following cell division to the point where DNA synthesis starts,
known as the presynthetic phase G1.
 After mitosis some of the daughter cells pass into a resting phase or non
proliferative phase G0 and do not re-enter the cell cycle phase G1 immediately.
They may enter the G1 phase later.
 DNA synthesis phase (S).
 The premitotic or postsynthetic (G2) phase fallows. In this phase RNA and
protein synthesis takes place.
 Mitotic phase (M) follows.
1.10. Criteria for Antineoplastic Drug (Anticancer drug)
The term ‘anticancer drug’ is emotive and can build up false hopes among cancer
sufferers. Investigator in the United States National Cancer Institute (NCI) program
have used the term cytotoxic, antitumour and anticancer to describe the activity of the
compound isolated according to the following definitions.  A cytotoxic agent is toxic
to tumour cell in- vitro and if this toxicity transfers through the tumour cell in vivo,
the agent is said to have antitumour activity.  The term anticancer is reserved for
material, which are toxic to tumour cell in clinical trials.
An antineoplastic drug should be:
(1) Cytotoxic: To inhibit the cancer cell metabolism, particularly synthesis of
protein and nucleic acid, in order to prevent cell growth, differentiation,
vascularization of the new growth etc.
(2) Mitostatic: To disrupt the process of cell division, to prevent the uncontrolled
number of cycles of cell division and growth, to retard the proliferation of the
cancerous tissue.
(3) Nontoxic: The drug should be nontoxic to the rest of the body of the patient; it
should not cause any side effect such as renal or hepatic dysfunction,
neurotoxicity, hypersensitivity etc.
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(4) Target oriented: It should be site-selective targeting in action to the
cancerous region and not cause the same effect (or at least not cause them to
the same degree as on cancer) on the other part of patient’s body.
The drug should be effective in small and few doses, should not be expensive, should
have longer half-life, freely available on the market, etc., These criteria for an
anticancer drug are a tall order. Hardly there is any drug, synthetic or natural, that
meets with all these qualification and so the choice is dictated by the maximum
compliance of the criteria and the philosophy of the ‘Lesser evil’. With the presence
of a large number of different types of cancer, each a kind of a syndrome, no single
drug can be expected to be effective against more that are, at the best a few of related
cancers (Barar 2003; Singh & Lippman 1998).
1.11. Plants in the Treatment of Cancer
In the face of failure to find synthetic drugs against cancer, thousands species of
plants have been screened since a long time, for antineoplastic activity, in the hope of
discovering effective natural products. Compounds have been isolated from hundreds
of species and their activities in suppressing tumours induced in laboratory animals
have been evaluated. Such work is still going on in several laboratories throughout the
world. The Natural Product Drug Development Program of the U.S. National Cancer
Institute has identified about 3,000 species of plants and animals as useful in dealing
with one or the other aspect of cancer management. Basing on in vitro data, a large
number of species have been identified to be of promise and taken to clinical trials.
However, products of hardly a handful of plant species, such as the Vinca alkaloids,
taxol, camptothecin, podophyllotoxin, etc., have passed through the rigorous tests to
be officially used against certain types of cancer and are now available in the market.
Plants in the management of cancer
In addition to the handling of the cancer proper, a host of synthetic or plant based
drugs are used in the biomedical system in the management of cancer, which is
distinct from treatment aimed at a cure. The better hope of usefulness of plants lies in
the areas of detection, prevention, management of symptoms inherent in the disease or
incidental to the treatment, post-cure management such as the recovery of the body to
full and normal functioning, prevention of remission, and management of symptoms
of incurable cancers, to keep the patients in the maximum possible comfort.
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Plants in the prevention of cancer
There is a prevailing hope that ‘someday people should be able to avoid cancer or
delay its onset by taking specially formulated pills or foods. Chemoprevention is the
attempt to use natural and synthetic compounds to intervene in the early pre-
cancerous stages of carcinogenesis, before the invasive disease begins, as prevention
of cancer is immensely better than its uncertain cure.
Food has been identified as one of the most promising sources of chemopreventive
agents. These include vitamins A (and its analogues), C and E, which are obtained by
us only from plants. Some plant products without any recognised nutritional value
such as indoles, isothiocyanates, dithiolthiones and organosulphur compounds have
been shown to be chemopreventive. Dithiolthiones and organosulphur compounds are
abundant in broccoli, cauliflower and cabbage. Genistein from soyabean, and
epigallocatechin, the bulk of solid material in brewed tea have also been found to be
chemopreventive, as well as turmeric, ginger and saffron.
Among the plant-based chemopreventives, β-carotenes, the precursors of vitamin A,
are rated high. In addition to carrots, they are present in a large number of plants,
particularly abundant in the leafy vegetables. These food plants also provide the
dietary fibre that is believed to prevent colon cancer. It is not yet very clear how the
chemopreventive agents function. Some are believed to prevent the mutations that can
lead to cancer, some halt the process of excessive proliferation of altered cells, and
some hasten apoptosis (death of cells) of altered cells, while some function as
antioxidants and scavenge the free radicals that may trigger cancer (VandeCreek et
al., 1999).
1.12. Cancer Chemotherapy
The chemotherapy of neoplastic disease has become increasingly important in recent
years. An indication of this importance is establishment of a medical specialty in
oncology in which the physician practices various protocol of adjuvant therapy. Most
cancer patient now receives some form of chemotherapy, even though it is merely
palliative in many cases. The relatively high toxicity of most anticancer drugs has
fostered the development of supplementary drugs that may alleviate these toxic
effects or stimulate the regrowth of depleted normal cells. There is a cogent reason
why cancer is more difficult to cure than bacterial infections. One is that there are
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qualitative differences between human and bacterial cells. For example bacterial cell
have distinctive cell walls, and their ribosome differ from those of human cells. In
contrast, the differences between normal and neoplastic human cells are mostly
quantitative. Another difference is that immune mechanism and other host defenses
are very important in killing bacteria and other foreign cells, whereas they play a
lesser role in killing cancer cells.
1.13. Indian Scenario
The global context sketched above suggest several tremendous opportunities
for India, a country with unrivalled terms of diversity of medicinal systems
and practices, in addition to being a major storehouse of biological diversity,
with 2 of the 4 mega diversity areas of the world located within its borders.
In addition several concerns arise in relation to the current consequences of
participation in the
market, with regard to the sustainable and equitability of prevailing practices
in the
sector. To add to all these aspects, the market in India has been shown to be
highly inefficient and imperfect. The need of the hour then is to replant
India's participation in the expanding global market. Such an overview could
form the basis of a renewed development of India's medicinal plant sector,
and a strategic exploitation of other comparative advantage in the global
market on a sustainable and equitable basis.
1.14. Drug designing for cancer
In designing specific regimens for clinical use, a number of factors must be taken into
account. Drugs are generally more effective in combination and may be synergistic
through biochemical interactions. These interactions are useful designing new
regimens.  It is more effective to use drugs that do not share common mechanisms of
resistance and that do not overlap in their major toxicities. Drugs should be used as
close as possible to their maximum individual dose and finally, drugs should be used
as close as possible to discourage tumor growth and maximize dose intensity (the
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dose gives per unit time, a key parameter in the success of chemotherapy).  Based on
experimental tumor models, it is necessary to eradicate all tumor cells. The fraction of
cells killed with each treatment cycle is constant, with regrowth between cycles. Thus,
it is desirable to achieve maximal cell kill with each cycle, using the highest drug dose
possible, and to repeat dose as frequently as tolerated.  Since the tumor cell population
in patients with visible disease exceeds 1gm, or 109 cells, and since each cycle of
therapy kills less than 99% of the cells, it is necessary to repeat treatments in multiple
cycles to kill all the tumor cells.
The activity of many of the drugs currently used in cancer chemotherapy can probably
be ascribed to inhibition of nucleic acid synthesis, but mechanism of action differs
widely. Some compounds are mitotic inhibitors for example colchicine,
podophyllotoxin, vincrystine and maytansine, and they act by binding to the protein
tubulin in the mitotic spindle, preventing polymerization and assemble into
microtubules, and after cell division, the microtubules are transformed back to
tubulin.
Although podophyllotoxin is a tubulin binder, it is intriguing that the semisynthetic
anticancer drugs etoposide and teniposide derived from it have a different mode of
action. These drugs inhibit DNA synthesis and replication via the enzyme
topoisomerase II. Camptothecin derivatives, topotecan and irinotecan, exert their
cytotoxic action through inhibition of topoisomerase I system. Topoisomerase are
fundamental enzyme complex involved in DNA replication by their ability to break
and reseal the DNA strands.
With the identification of an increasing number of molecular targets associated with
particular cancers, high throughput screening of compounds against a range of such
targets now forms the basis of anticancer drug discovery. Examples are the cyclin
dependant kinases, which, together with their cyclin parameters, play a key role in the
regulation of cell cycle progression, and inhibition of their activity delays or arrest
progression at specific stages of cell cycle. These are over 2000 kinases so for
identified for genomic studies and all have a common site, the position where the
ATP, that is, the source of phosphate that is donated, is bound. The moderately
antitumor flavonoids, quercetin, is an early example of natural product compound
class that ultimately led to CDK inhibitors. These flavonoids resembles an ATP
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mimic where the planar bicyclic chromone ring system is an isostere of adenine.
Quercetin exerts its antitumor effect through blocking cell cycle progression at the
G0/G1 interface, consistent with Cyclin dependant kinase inhibition.
Taxol is a naturally occurring highly derivatised diterpene belonging to taxane group
of compounds present in genus Taxus under family Taxaceae.  A derivative of taxol-
taxofere has been reported to have better bioavailability and pharmacological
properties.  The bio target of taxol is microtubule responsible for formation of mitotic
spindle necessary for cell division which causes detrimental effects leading to
blockage of cell cycle (Wilson and Gisvold 2004).
1.15. Antioxidants
Cells in human body use oxygen to breakdown carbohydrates, proteins and fats that
give them energy. Metabolically active cells produce by products called free radicals.
These are atoms or groups of atoms or groups of atoms that have at least one unpaired
electron, which make them highly reactive. They promote beneficial oxidation that
produces energy and kill bacterial invaders. If free radicals are at reasonable levels the
human body produces enzymes to combat them and useful immune system and
antibacterial cell activity.
It is well known that the reactive oxygen species (ROS) are involved in many
pathological disorders such as atherosclerosis and related cardiovascular diseases,
diabetes, and cancer. Reactive oxygen species, generated in vivo mainly by
neutrophills, macrophages and xanthenes oxidase system, appears to be responsible in
these illnesses by inducing lipid peroxidation via a chain reaction process. Most living
species have protective systems against oxidative stress and toxic effects of ROS.
Several studies have demonstrated that the antioxidant properties of plant compounds
could be correlated with oxidative stress defense. Thus antioxidant compounds can be
used to counteract oxidative damage by reacting with free radicals, chelating free
catalytic metals, and also by acting as oxygen scavengers.
Antioxidants are compounds which act as inhibitors of the oxidative process. They are
quite large in number and diverse in nature, which oppose the process of oxidation
largely by neutralizing free radicals. Antioxidants at relatively small concentrations
have the potential to inhibit the oxidants chain reactions. Antioxidants are also of
17
paramount importance in pharmaceutical formulation because there are innumerable
medicinal agents possessing diverse chemical functions and are known to undergo
oxidative decomposition. The enzymatically potential antioxidants known are
superoxide dismutase, glutathione peroxidase, catalase and peroxidases.
In the non enzymatic category, some of the known and documented antioxidants are
vitamin C, vitamin E, vitamin A, ß carotenoids, uric acid, ubriquinone and synthetic
compounds like melatonin, dihydro epiandrosterone (DHEA) etc. Some of the plant
product or extracts viz. Ginkgo biloba extract, spirulina, various spices, like the
extract of garlic and onion, turmeric, capsicum, black pepper, amla, tomato, guava,
watermelon, tea beverages have been also be reported antioxidants of non-enzymatic
category.
1.16. Antioxidant defence
Antioxidant means “against oxidation”. Antioxidants work to protect lipids form
peroxidation by radicals.  Antioxidants are effective because they are willing to give
up their own electrons to free radicals.  When a free radical gains the electron from an
antioxidant it no longer needs to attack the cell and the chain reaction of oxidation is
broken15.  After donating an electron an antioxidant becomes a free radical by
definition.  Antioxidants in this state are not harmful because they have the ability to
accommodate the antioxidant defense system.  Antioxidants are manufactured within
the body and can also be extracted from the food humans eat such as fruits,
vegetables, seeds, nuts, meats, and oil.  There are two lines of antioxidant defense
within the cell.  The first line, found in the fat-soluble cellular membrane consists of
vitamin E, β-carotene, and coenzyme (Dekkers et al., 1996).
Antioxidant tends to reduce free radical formation and scavenge free radical. Despite
the fact that humans have evolved with antioxidant system to protect against free
radicals, which may be endogenous or exogenous, some ROS still escape in quantities
sufficient enough to cause damage.  Therefore exogenous antioxidants that scavenge
free radicals, especially, those from the relatively harmless natural sources play an
important role in cardiovascular disease, aging, cancer and inflammatory disorders as
well as in ameliorating drug-induced toxicity.  This has accelerated the search for
potential antioxidants from traditional medicinal plants (Kaczmarski et al., 1999;
Veeresham & Asres 2005).
18
2. Plant Profile
(Wealth of India, 2003 [Anon]; Devasagayam 2007; Wealth of India, CSIR, 1969;
Indian Medicinl Plants [Kitikar & Basu] 1975, 1987, 1999; The Flora of Orissa;
Saxsena & Brahmam, 1994; Sharma et al., 2005; Sharma 2003; Swain & Das 2007;
Nadkarni 1976; Kapoor, 1989).
Botanical Name: Pterocarpus marsupium Roxb.
Botanical Source: The plant consists of the bark, leaves, heartwood of Pterocarpus
marsupium P. marsupium
Order: Fabales
Family: Leguminosaa (Fabaceae)
Subfamily: Faboideae
Tribe: Dalbergieae
Genus: Pterocarpus
Species: marsupium
Authority: Roxb.
Vernacular names: (Sharma 2003; Swain & Das 2007)
1. Sanskrit: Pitasala, Bijaka, Murga
2. Hindi: Bijasal
3. English: Malabarkino; Indian Kino Tree
4. Bengali: Pitsal
5. Nepalese: Bijasar
6. Sinhalese: Gammalu
7. German: Malabarkino
8. Kannada: Honne
8. French: Pterocarp
9. Unani: Dammul-akhajan
10. Arabian: Dammul Akhwayn
11. Persian: Khoon-e-siyaun-shan
12. Tamil: Vengai
13. Telugu: Yegi
14. Malayalam: Venga
P. marsupium, also known as Malabar kino, (Gamble, 1935) Indian kino tree or
vijayasar, is a medium to large, deciduous tree that can grow up to 30 metres tall. It is
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native to India, Nepal, and Sri Lanka, where it occurs in parts of the Western Ghats in
the Karnataka-Kerala region and also in the forests of Central India. Parts of the
Indian kino (heartwood, leaves, and flowers) have long been believed to have
medicinal properties in Ayurveda (The Flora of Orissa, Saxsena & Brahmam, 1994).
In Karnataka the plant is known as honne or kempu honne. The Kannada people in
India make a wooden tumbler from the heartwood of this herb tree (Saldanha, Flora
of Karnataka, 1984).
Bark of Pterocarpus marsupium Leaves of Pterocarpus
marsupium
2.1 Habitat
A moderate to large deciduous tree about 90ft or more high, commonly found in hilly
region of central and peninsular India (Andhra Pradesh, Bihar, Gujarat, Kerala,
Madhya Pradesh, Maharashtra, Karnataka, Orissa, Tamilnadu, Uttar Pradesh); found
at 3000 ft in Gujarat, Madhya Pradesh and Himalayan & sub Himalayan tracts-Nepal
(Kapoor, 1989) and Sri Lanka. It grows on a variety of formation provided the
drainage is good. It prefers a soil with a fair proportion of sand though it is often
found on red loam with a certain amount of clay. The normal rainfall in its natural
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habitat ranges from 75 to 200cm but it attains its largest size in parts of Mysore and
Kerala, where the rainfall is even higher. It is a moderate light demander and the
young seedlings are frost-tender (Wealth of India, CSIR, 1969).
Parts used: Bark, Leaves, Kino (gum)
2.2 Pharmacognostical Characteristics
Morphology
It is a moderate-sized to large deciduous tree. bark grey, longitudinally fissured and
scaly. The older trees exude a blood red gum-resin.
Description
Leaves: compound; with 5 to 7 leaflets, 3 to 5 in long, oblong or elliptical with  wavy
margin or rounded or obtuse or retuse ends, glaucous beneath, secondary nerves close
and parallel, over 12 cm each side.
Flowers: yellow, , up to 1.5 cm long, corolla papilionaceous, exserted beyond calyx,
Stamen 10, split in 2 bundles , yellow, in very large, dense bunches.
Fruits: 2 to 5 cm long, roundish, winged, with one seed. Legume indehiscent,
orbicular, compressed, broadly hardened winged around margin, usually single
seeded, seeds subreniform, hilum small.
The Heartwood: is golden to yellowish brown with dark streaks staining yellow
when damp and turning darker on exposure, strong and tough.
2.3 Microscopic Characteristics
The wood consists of vessels, tracheids, fibre tracheids and wood parenchyma all the
elements being lignified and filled with tannin. Vessels are medium sized drum
shaped, scattered, leading to semiring-porous conditions, tyloses present. Tracheids
are long, abundant, thick walled, with tapering ends and simple pits on the side walls.
Xylem parenchyma is small, thick walled with blunt ends; rectangular simple pitted
surrounding the vessel. A few crystal fibers are observed in tangential section of the
wood. Tree bark yields a reddish gum known as Kino gum, which becomes brittle on
hardening and is very astringent. Sclerenchyma diffused pores Red marks are resin
canals 8 Stem hairs overlapping metaxylem and protoxylem.
2.4 Chemical Constituents
Researches in the past have established the genus Pterocarpus to be the rich sources
of polyphenolic compounds. All active principles of P. marsupium are thermostable.
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The primary chemical components of P. marsupium are pterosupin, pterostilbene,
isoliquiritigenin, liquiritigenin, epicatechin, kinotannic acid, kinoin, kino-red beta-
eudesmol,
marsupol, carpusin and marsupinol.
The plant contains pterostilbene 4- 5%, alkaloids 0.4%, tannins 5%, protein, pentosan,
pterosupin, pseudobaptigenin, liquiritigenin, isoliquiritigenin, garbanzol,
5- de- oxykaempferol, P- hydroxybenzaldehyde, beudesmol,
erythrodirol- 3- monoacetate, l- epicatechin, marsupol, carpusin, propterol, propterol B,
marsupinol, irisolidone- 7-  O- A- L- rhamnopyranoside, have been obtained mainly
from the heartwood and root.
The gum kino from the bark provides non- glucosidal tannins - kinotannic acid,
kinonin (C28H24O12), kino- red (C28H22O11),pyrocatechin, pyrocatechin acid &
small quantities of resin, pectin and gallic acid.
Aqueous extract of the heartwood of Pterocarpus marsupium contains 5 new
flavonoids C- glucosides namely 6- hydroxyl- 2- (4- hydroxybenzyl)- benzo-
furan- 7- C- â- D- glucopyr anoside, 3- (á - methoxy- 4- hydro xybenzylidene)
- 6- hydroxybenzo- 2(3H)- furanone- 7- C- â-  D- glucopyranoside, 2- glucopyranoside,
8- (C- â- D- glucopyranosyl)-  7,3,4- trihydroxyflavone and 1,2- bis (2,4- dihydroxy,
3- C- glucopyranosyl) – ethanedione and two known compounds C- â- D-
glucopyranosyl- 2,6- dihydroxyl benzene and sesquiterpene were isolatedEther extract
of the roots of Pterocarpus marsupium consists of a new flavonol glycoside 6-
hydroxy- 3,5,7,4- te tramethoxyflavone 6- O- rhamnopyranoside, 8­hydroxy­4’­m
ethoxyisoflavone- 7- O- glucopyranoside.
A benzofuranone derivative 2,4’6­trihydroxy­4­methoxy benzofuran­3(2H)-one
designated carpus in, 1,3- bis(4- hydroxyphenyl) propan- 2- ol designated propterol,
1- (2,4- di hydroxyphenyl )- 3- (4- hydroxyphenyl ) propan- 2- ol designated propterol,
6- hydroxy- 7- O-  methyl- 3- (3- hydroxy- 4- O- methyl benzyl) chroman- 4- one.Ethyl
acetate extract of root contains benzofuranone, marsupin, dihydrochalcone,
pterosupin, stilbene, pterostilbene, aliquiritigenin, isoliquiritigenin.
Methanolic extract of heart wood c ontains an isoflavone  7- O- á- L- rhamno-
pyranosyloxy­4’­methoxy­5­hydroxy­isoflavone. Three new isoflavone glycosides
viz retusin 7- glucoside, irisolidone 7- rhamnoside and 5,7- dihydroxy- 6- methoxy
22
isoflavone 7- rhamnoside have been isolated from the heartwood of Pterocarpus
marsupium. 2,6-
dihydroxy- 2- (P- hydroxybenzyl)- 3(2H)- benzofuran- 7- C- â- D- glucopyranoside
(Maurya et al., 2004; Gairola et a., 2010; Yogesh et al., 2010; Tiwari & Khare 2015).
2.5 Ethnomedicinal Uses (Tiwari et al., 2015)
Useful parts of the herb are heartwood, leaves, flowers, gum. The genus is widely
distributed on the Earth and the astringent drug from this genus is known as “Kino”.
The phloem of stem contains red astringent fluid present in secretory cell, which
exudes after given incision. Kino is odourless but has astringent taste and sticks in the
teeth, colouring the saliva red in colour. As astringent it is used in diarrhoea,
dysentery etc.
Bruised leaves are applied on fractures, leprosy, leucoderma, skin diseases, sores and
boils, Constipation, depurative, rectalgia, opthamology, hemorrhages and Rheumatoid
arthritis. Marsupin and Pterostilbene significantly lower the blood glucose levels
useful in NIDDM. Bark is used as diuretic in Gabon and fresh leaves are used as food
in Nizeria. Also is used in the form of powder or decoction in diarrhoea, and
decoction is very useful for diabetic patients.
Stem in the treatment of neurological problems.
Leaves are used in GIT disorders, wood, stem bark, seed and flours are used in
African traditional medicine, especially in the Cameroonian pharmacopoeia, for
treating various diseases including hypertension, diabetes, intestinal parasitizes, renal
and cutaneous diseases. The leaf paste is used as an ointment to treat skin diseases,
sores and boils.
Wood: The heartwood is used as an ointment to astringent, bitter, acrid, cooling, anti-
inflammatory, union promoter, depurative, urinary astringent, haemostatic,
asthelmintic, constipating, anodyne alterant and rejuvenation. It is also useful in
elephantiasis, inflammations, fractures bruises, leprosy, skin disease, leucoderma,
erysipelas urethrorrhoea, diabetes, rectalgia, rectitis, opthalmopathy, diarrhea,
dysentery, cough, asthma, bronchitis and greyness of hair.
Flower: The flower is used as appetizing and febrifuge and also taken to treat
anorexia and fever.
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Gum-resin: The gum is taken to treat bitter, styptic, vulnerary, antipyretic,
anthelmintic and liver tonic. It is useful in spasmodic gastralgia, boils, gleet,
urethrorrhoea, odontalgia, diarrhea, psoriasis, wound and ulcers, helminthasis, fevers,
hepatopathy and ophthalmia.
Some facts: P. marsupium is a plant drug belonging to a group called ‘Rasayana’ in
Ayurvedic system of medicine. These ‘Rasayana’ drugs are immunomodulators and
relieve stress in the body. In India, Kannada peoples are used to make a wooden
tumbler from the heartwood. Water is left overnight in the wooden tumbler and is
consumed in the next morning to cure diabetes. Kol tribes in Odisha pound a paste
mixture of the bark of P. marsupium with the bark of Mangifera indica, Shorea
robusta & Spondias pinnata to treat some dysentery illness. The gum resin of this
plant is the only herbal product ever found that regenerate beta cells that produce
insulin in pancreas.
2.6 Biological activity
Although a large number of compounds have been isolated from various parts of P.
marsupium, few of them have been studied for biological activity as shown in Table
1. The structure of some of these bioactive compounds has been presented in Figure
1. The bark contains l-epicatechin and a reddish brown colouring matter. The bark is
occasionally employed for dyeing. The heartwood yields liquiritigenin,
isoliquirtigenin, a neutral unidentified component, alkaloid and resin. The wood also
contains a yellow colouring matter and an essential oil and a semi-drying fixed oil.
The tree yields a gum-Kino which exudes when an incision is made through the bark
up to the cambium. It is odourless and bitter with astringent taste and colours saliva
pink when masticated. Kino contains a non-glucosidal tannin kinotannic acid, kinoin
and Kino-red, small quantities of catechol, protocatechuic acid, resin, pectin and
gallic acid. The therapeutic value of Kino is due to Kino is due to kinotannic acid.
Kino is powerfully astringent and was formerly used widely in the treatment of
diarrhea and dysentery. It is locally applied in leucorrhoea and in passive
haemorrhages. It is also used for toothache. The bark is used as an astringent and in
toothache. The flowers are said to be used in fever. The bruised leaves are considered
useful as an external application for boils, sores and skin diseases. The aqueous
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infusion of the wood is said to be of use in diabetes and water stored in vessels made
of the wood is reputed to have antidiabetic qualities (Anon, Wealth of India, 2003).
2.7 Medicinal use of various parts of P.marsupium
Various parts of the P. marsupium tree have been used as traditional ayurvedic
medicine in India from time immemorial. The medicinal utilities have been described,
especially for leaf, fruit and bark. The bark is used for the treatment of stomachache,
cholera, dysentery, urinary
complaints, tongue diseases and toothache. The gum exude ‘kino’, derived from this
tree, is used as an astringent (Singh et al., 1965). The gum is bitter with a bad taste.
However, it is antipyretic, anthelmintic and tonic to liver, useful in all diseases of
body and styptic vulnerant and good for griping and biliousness, opthalmiya, boils
and urinary discharges. The flowers are bitter, improve the appetite and cause
flatulence (Indian Medicinal Plants 1999). P. marsupium has a long history of use in
India as a treatment for diabetes. It is a drug that is believed to have some unique
features such as beta cell protective and regenerative properties apart from blood
glucose reduction (WHO 1980; Chakravarthy et al., 1981). Some of the medicinal
attributes of various parts of P. marsupium have been summarized (Yogesh et al.,
2010) in table 2.
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3. Literature Review
3.1. Anti-diabetic and antioxidant activity
P. marsupium demonstrates unique pharmacological properties, which include beta
cell protective and regenerative properties as well as blood glucose lowering activity.
The animal studies conducted have used various species including rats, dogs, and
rabbits with induced diabetes and subsequent treatment with various extracts of P.
marsupium. In all of these studies, P. marsupium was found to reverse the damage to
the beta cells and actually repopulate the islets, causing a nearly complete restoration
of normal insulin secretion (Chakravarthy et al., 1982; Manickam et al., 1997; Ahmad
et al., 1991; Pandey & Sharma 1976; Shah 1967; Chakravarthy et al., 1982).
In one study it was shown that aqueous extract of P. marsupium modulates the
inflammatory cytokine TNF-alpha in type 2diabetic rats and this has an indirect effect
on PPAR-Gamma expression. By decreasing TNF-α, drug can upregulate the PPAR-
Gamma and in turn the glucose metabolism (Halagappa et al., 2010).
The bark of P. marsupium is traditionally used in the Indian Ayurvedic system of
medicine as an anti-diabetic drug. The compound that is responsible for antidiabetic
activity is (-) epicatechin, a member of the catechin group of compounds belonging to
the class of flavonoids (Zaid et al., 2002).
It has been shown that P. marsupium works by the regeneration of the beta cells and
increase proinsulin biosynthesis. Marsupin and Pterostilbene significantly lowered the
blood glucose level of hyperglycemic rats, and the effect was comparable to that of
1,1-dimethyl biguanide (metformin)  (Manickam et al., 1997).
Overnight water stored in water tumblers made out of the heartwood of P. marsupium
is used as a traditional therapy for patients of Diabetes mellitus especially in the state
of Madhya Pradesh (Maheswari et al., 1980).
Isolated compounds from P. marsupium have been shown to enhance the conversion
of Pro-insulin to insulin and stimulate cAMP content in the islets of Langerhans
(Ahmad et al., 1991).
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It is proposed that the flavonoid fraction of P. marsupium bark effectively reverses the
alloxan induced changes in the blood sugar level and the beta cell population in the
pancreas (Chakravarthy et al., 1980).
P. marsupium methanol extract has been found to cause normalization of serum
protein and albumin levels, possibly through the increase in insulin mediated amino
acid uptake, enhancement of protein synthesis and inhibition of protein degradation
(Dice et al., 1978).
Administration of the bark extract to diabetic rats restored the levels of serum
electrolytes, glycolytic enzymes and hepatic cytochrome p-450 dependent enzyme
systems by inhibiting the formation of liver and kidney lipid peroxides (Gayathri and
Kannabiran et al., 2010).
3.2. Cardiotonic activity
Cardiotonic activity was reported of the aqueous extract of heartwood of P.
marsupium. This plant species contains 5,7,2-4 tetrahydroxy isoflavone 6-6 glucoside
which are potent antioxidants and are believed to prevent cardiovascular diseases. The
cardiotonic effect of the aqueous extract of heartwood of P. marsupium was studied
by using the isolated frog heart perfusion technique. Calcium free Ringer solution was
used as vehicle for administration of aqueous extract of P.marsupium as a test extract
and digoxin as a standard (Mohire  et al., 2007). Liquiritigenin and Pterosupin, the
flavonoid constituents of P. marsupium are effective against reducing serum
cholesterol levels, LDL cholesterol, and atherogenic index. Pterosupin being
additionally effective in lowering serum triglycerides (Jahromi and Ray.,1993).
3.3. Hepatoprotective activity
Methanol extract of the stem barks of P. marsupium possesses significant
hepatoprotective activity (Mankani et al., 2005).
3.4. Antioxidant activity
The whole aqueous extract of the stem bark of P. marsupium showed high anti-
oxidant activity and protects the mitochondria against oxidative damage (Mohammadi
et al., 2009).
27
Heartwood extracts of P. marsupium promotes wound healing in both normal and
diabetic animals by topical application of the extracts (Singhal et al., 2013).
Ethanol extracts of the heartwood of P. marsupium is found to be useful in preventing
allergic conditions and diseases such as asthma owing to its ability to decrease the
increased eosinophilic , leucocytic count, prevention of mast cell degranulation
(Suralkar et al., 2012).
Antidiarrhoeal activity of Ethanol heartwood extract of Pterocarpus marsupium was
also studied (Dilpesh et al., 2011).
3.5. Antibacterial activity
Hexane, ethyl acetate and methanol extracts were tested against four selected Gram
positive and Gram negative bacteria- S. aureu, K. pneuminiae, and P. aeruginosa
(Sapha 1956; Gayathri and Kannibaran ., 2010). In vitro, it inhibits Pseudomonas
aeruginosa, Streptococcus pyrogens and Staphylococcus aureus. Ethyl and methanol
extracts were more sensitive to the bacteria than extracts made out of hexane. Both
the extracts exhibited concentration dependent variation in their anti-bacterial activity.
Similar observations have been reported where it has been showed that ethanol
extracts of P. marsupium exhibited significant anti-ulcer and antioxidant properties in
rats (Nair et al., 2005; Patil & Gaikwad, 2011).
3.6. Anti-inflammatory activity
P. marsupium has also shown strong potential for its antiinflammatory activity. In this
study, an extract of P. marsupium containing pterostilbene has been evaluated for its
PGE2- inhibitory activity in LPS-stimulated PBMC. In addition, the COX-1/2
selective inhibitory activity of P. marsupium extract was investigated (Hougee et al.,
2005; Salunkhe et al., 2005).
3.7. Central Nervous System
The methanol extracts of P. marsupium has potent nootropic activity (Chauhan and
Chaudhary, 2012).
3.8. Other Studies
Anti-cataract activity of P. marsupium in diabetes was observed (Vats et al., 2004).
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Lukewarm aqueous suspension of 2g gum with jaggery is given early in the morning
for a week to treat asthma (Patil et al., 2008).
Bark is useful in vitiated condition of kapha, pitta, elephantiasis, erysipelas,
urethrorrhea, rectalgia, opthalmopathy, hemorrhages, dysentry, cough, and grayness
of hair (Patil and Gaikwad., 2011).
20g of the stem bark boiled with 1 litre of water till 200ml along with 7 black pepper
dried seeds of Piper nigrum) taken orally cures spermaturia, spermatorrhea,
leucorrhoea, amenorrhoea, dysmennorhoea, menorrhagia and impotency (Behera and
Mishra ., 2005).
Table 1. Primary chemical components from Pterocarpus marsupium
Neem compound Source Biological Reference
Liquiritigenin bark Antidiabetic,
Antihyperlipidemic effect
Jahromi & Ray 1993
Isoliquiritigenin bark Antidiabetic Jahromi & Ray 1993
Pterosupin Antihyperlipidemic effect Jahromi & Ray 1993
Epicatechin bark Antidiabetic, Anthelmentic
properties
Pterostilbene bark blood glucose levels, Anti-
oxidant and anti tumor
effects
Grover et al., 2005
Marsupinol bark Antihyperlipidemic effect Jahromi & Ray 1993
Table 2. Some medicinal uses of Pterocarpus marsupium as mentioned in
Ayurveda
Parts Medicinal use
Leaf External application for boils, sores and
skin diseases, stomach pain
Bark Astringent, toothache
Flower Fever
Gum-Kino Diarrhea, dysentery, leucorrhoea, passive
haemorrhages
3.9. Clinical studies and plausible medicinal applications
Although studies have been carried out on various biological activities of P.
marsupium extracts and some of the isolated compounds in several animal models, a
few reports are available on clinical studies with the extracts or the compounds and
their medicinal applications (Anon, Wealth of India, 2003). Pterocarpus marsupium
(PMS, Leguminnaceae family), commonly known as Bija, that has been
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recommended as early as 1000 BC, by Sushruta for the treatment of diabetes. Various
reports indicate the hypoglycemic activity of PMS both in experimental and clinical
studies (Pandey & Sharma 1976; Remsberg et al., 2008; Manlio et al., 2005).
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4. Aim and objective of the study
Since pre-historic days attempts are being made to find out suitable drugs from
natural sources for treatment of different diseases. The rational approaches,
experience of folk medicine provide a valuable approach in the search for the
development of new and useful therapeutic agents. Gradually keeping in pace with the
scientific interpretations of the drug actions, the causes of the diseases, and the
development in the field of chemistry and technology, intensive efforts are being
directed towards the design and synthesis of new drugs.
More recently a study by the World Health Organization (WHO) has shown that
about 80% of the World’s population still relies on traditional medicine.  This is of
interest to a natural product chemist for many reasons. There is the possibility that the
herb used in the traditional medicine is harmful to the patient, in which case the
treatment may do more harm the good. Conversely, there is the possibility that the
herbs used are not effective at all. That may not be of concern for minor ailments, but
in more serious cases an ineffective treatment could result in the death of the patient.
Hopefully, however, the herbs used are effective. If that is the case then investigation
of that remedy could be of benefit to the remaining 20% of the World’s population.
Natural products still play a very important role in the medicine of the remaining 20%
of the world’s population. Between 1983 and 1994, 41% of new approved drugs have
natural products as their source. This percentage becomes even higher when one
examines anti-infective and anticancer compounds. For both classes, the percentage of
drugs with natural products as their source increases to over 60%.
Because natural products are most important in the areas of anti-infective,
antioxidants and anticancer agents, some of the important contributions to these drug
classes are worth closer inspection. In particular the anticancer drugs will be
examined as that is the area of our research.
Cancer is a multifactorial, multifaceted and multimechanistic disease requiring a
multidimensional approach for its treatment, control and prevention. Cancer involves
fundamental biological processes concerning disorganised cell replication, cell death
and disorganization of organ structure. The annual estimates of cancer for the year
2001 in India is 0.98 million and the annual mortality in 2000 is 0.7 million. The
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incidence of cancer is on the rise, with multiple risk factors that involve interplay
between genetic and environmental components.
The aim of the research is to find out new anticancer drugs from indigenous plants
which are potent and nontoxic agents. These plants are traditional medicinal plants.
Their chemical characterization, mode of action and toxicity studies are yet to be
established. Present project deals with phytochemical and pharmacological evaluation
of Triumfetta rhomboidea, Adiantum venustum, leaves and stem with special
reference to in-vitro studies like antioxidant, cytotoxicity and in-vivo studies like
anticancer, antioxidant, analgesic, antipyretic, anti-inflammatory, and wound healing
in animal models. Normally herbal products are free from side effects/adverse effect
and they are low cost medicines, which will be beneficial for the people of this
country. Keeping this in view, we have selected two plants from the Kolli hills,
Namakkal District of Tamil Nadu which are used by the tribes for the treatment of
different types of diseases. The main objective of this work is to develop potent
anticancer agent having no minimum side effects from indigenous plants for the
therapeutic management.
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5. Plan of work
Phase I:
5.1. Phytochemical studies:
 Collection and authentication of plants.
 Extraction of plant material by using a suitable solvent system.
 Preliminary phytochemical study for the identification of plant secondary
constituents.
Phase II:
5.2. Pharmacological studies:
 Acute oral toxicity and sub-acute toxicity studies
 In-vitro antioxidant studies:
DPPH assay
Scavenging of Nitric Oxide radical assay
Scavenging of ABTS radical cation assay
Hydroxyl radical scavenging activity
 In-vitro Cytotoxicity studies:
Determination of cell viability by MTT assay
Cytotoxicity tests are being used for the anticancer screening of drugs. A
novel anticancer drug should possess cytotoxicity at low concentration against
cancerous cell line and should be safe against normal cell lines even at higher
concentrations.
Cytotoxicity can also be monitored using the MTT or MTS assay. This assay
measures the reducing potential of the cell using a colorimetric reaction.
Viable cells will reduce the MTS reagent to a colored formazan product.
Hence, the ethanol extract of Pterocarpus marsupium bark was tested for
cytotoxicity study by Micro culture Tetrazolium (MTT) assay method
(Sreejayan & Rao 1996; Halliwell & Gutteridge 1998; Scudiero et al., 1998;
Ruby et al., 1995; Francis & Rita, 1986).
Phase III:
5.3 Statistical Analysis
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The data’s were presented as mean ± SEM and were subjected to statistical
analysis by Dunnett’s test followed by one way ANOVA. P-value less than
0.05 were considered statistically significant.
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6. Materials And Methods
6.1. Phytochemical Studies
Collection and Authentication of the Plant
The bark of P. marsupium were collected in the month of October 2015, from Kolli
Hills, Namakkal district of Tamil Nadu state, India.  The collected plants were
authenticated by the Dr. G. Murthy, Botanical survey of India, Coimbatore, Tamil
Nadu and the voucher specimen has been preserved in our laboratory for future
reference (BSI/SC/5/PG/15-16/OCT).
6.1.1 Extraction of Pterocarpus marsupium bark using ethanol
The bark of the tree were dried under shade with occasional shifting and made into
coarse powder with a mechanical grinder. The powder material were first passed
through sieve No.40 and then defatted with petroleum ether. The defatted powder
materials thus obtained were further extracted by ethanol for 72 hours in a Soxhlet
extraction apparatus.  The solvent was removed under reduced pressure and a
semisolid mass was vacuum dried so yields a solid residue. After complete drying, the
extract material was weighed and the extractive value in percentage was calculated
with reference to the air dried sample (Harborne 2005). Thus an ethanol extract of
Pterocarpus marsupium bark (EEPM) was obtained.
6.1.2. Preliminary phytochemical studies on ethanol extract of EEPM bark
The ethanol extracts were subjected to qualitative tests for the detection of various
plant constituents like carbohydrates, glycosides, proteins and amino acids, fixed oils
and fats,gums and mucilages, alkaloids, phytosterols, flavanoids, tannins and phenolic
compounds, saponins, triterpinoids etc.
Phytochemical Test
The methanol extracts of P. marsupium was subjected to various colour reactions to
identify the nature of the components (Krishnaswamy, 2003).
i. Test for Carbohydrates
Small quantities of the extracts were dissolved separately in 4ml of distilled water and
filtered and the filtrate was subjected to Molisch’s test to detect the presence of
carbohydrates.
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a) Molisch’s test: The Molisch’s reagent was prepared by dissolving 10 gm of -
napthol in 100ml of 95% alcohol. 1ml of filtrate was mixed with 2 drops of
Molisch’s reagent. To this solution, was added 1ml of concentrated sulphuric acid
from the side of the inclined test tube, so that two acids formed a layer beneath the
aqueous solution without mixing with it. If a red brown ring appears at the
common surface of the liquids, sugars are present
b) Iodine Test: The iodine solution was prepared by dissolving 2 gm of iodine and 3
gm of potassium iodide in 100ml water.  1ml of above filtrate was mixed with
iodine solution, if blue colour appears, sugar is present.
ii. Test for Glycosides
A few mg of residue was dissolved in 4ml of distilled water and filtrated, and
collected the filtrate.
a) Legal Test: 2ml of filtrate was hydrolysed with dilute hydrochloric acid and
heated on a water bath.  Then added 1 ml of pyridine and few drops of sodium
nitroprusside solution and made alkaline with sodium hydroxide solution.
Appearance of pink colour shows the presence of glycosides.
b) Borntrager’s test: 2ml of filtrate was hydrolyzed with dilute hydrochloric acid
and heated on a water bath then treated with chloroform and shaken, after that
separated the chloroform layer and added equal quantity of dilute ammonia
solution.
iii. Test for Flavonoids
a) 5ml of extract was hydrolyzed with 10% v/v sulphuric acid and cooled.  Then
it was extracted with diethyl ether.  The ether extract was divided into three
portions in three separate test tubes. 1ml of dilute ammonia, 1ml of dilute
sodium bicarbonate and 1ml of 0.1N sodium hydroxide were added to the 1st,
2nd and 3rd test tubes respectively. In each test tube development of yellow
colour indicates the presence of flavonoids.
b) A few mg of extract was mixed with dilute sulphuric acid.  Development of
yellow to crimson colour shows the presence of flavonoids.
c) Shinoda test: The extracts were dissolved in alcohol. One piece of
magnesium followed by concentrated hydrochloric acid was added drop wise
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and heated. Appearance of magenta colour demonstrated the presence of
flavonoids.
iv. Test for Phytosterols
a) Salkowaski test: 10 mg of extract was dissolved in 2ml of chloroform and 2ml of
concentrated sulphuric acid was added from the side of the test tube. The test tube
was shaken for few minutes.  The development of red colour in chloroform layer
indicated the presence of sterols.
b) Liebermann’s test: To 10 mg of the extract in a test tube, 1ml of acetic anhydride
was added and gently heated. The contents of test tube were cooled. Few drops of
concentrated sulphuric acid were added from the side of the test tube.  A blue
colour gave the evidence of presence of sterols.
c) Liebermann-Burchard Test: 1ml of concentrated sulphuric acid was added to 10
mg of extract in 1ml of chloroform.  A reddish-blue colour exhibited by
chloroform layer and green fluorescence by the acid layer suggests the presence of
sterols.
d) Few mg of extract was dissolved in vanillin solution (100 mg of vanillin dissolved
in concentrated sulphuric acid-ethanol in proportion of 4:1) development of Blue
to brown colour indicates the presence of sterols.
v. Test for Alkaloids
Few mg of extract was taken in 5ml of 1.5% v/v hydrochloric acid and filtered. These
filtrates were then used for testing alkaloids.
a) Dragendorff’s reagent: The extract was treated with Dragendorff’s reagent
(Potassium bismuth iodide). Formation of orange-brown precipitate shows the
presence of alkaloids.
b) Mayer’s reagent: It was prepared by dissolving 1.36 gm of mercuric chloride in
60ml distilled water, added it to a solution of 5 gm of potassium iodide in 20 ml
distilled water making volume to 100ml. To a 1ml of test filtrate in a watch glass,
a few drops of above reagent were added.  The formation of cream coloured
precipitate shows the presence of alkaloids.
c) Wagner’s Reagent: It was prepared by dissolving 1.27 gm of iodine and 2 g of
potassium iodide in 5ml of water and made up the volume to 100ml with distilled
water.
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When few drops of this reagent was added to the filtrate, if it shows reddish brown
precipitate indicates the presence of alkaloids.
d) Hager’s reagent: A saturated aqueous solution of picric acid was employed for
this test.  When the test filtrate was treated with this reagent, an orange yellow
precipitate was formed which indicates the presence of alkaloids.
vi. Test for Tannins
The test extract was taken in water, warmed and filtered.  Tests were carried out with
the filtrate using following reagents.
a) Ferric chloride test: 5ml of filtrate was allowed to react with 1ml of 5% ferric
chloride solution.  If dark green or deep blue colour is obtained, tannin is present.
b) Lead acetate test: 5ml of filtrate was treated with 1ml of 10% lead acetate
solution in water. Yellow colour precipitate demonstrated the presence of tannins.
c) Potassium dichromate test: 5ml of filtrate was treated with 1ml of 10% aqueous
potassium dichromate solution. If yellowish-brown precipitate formed, it suggests
the presence of tannins.
d) Bromine water test: Bromine solution was added to the test filtrate.  If
depolarization of bromine water occurs, tannins are present.
e) Gelatin Solution test: 1% w/v solution of gelatin in water, containing 10%
sodium chloride was prepared. A little of this solution was added to the filtrate. If
white precipitate is obtained, tannins are present.
vii. Test for Saponins
a) Foam test: 1ml solution of extract was diluted with distilled water to 20ml and
shaken in a graduated cylinder for 15 minutes.  Development of stable foam
suggests the presence of saponins.
b) 1ml extract was treated with 1% lead acetate solution. Formation of white
precipitate indicates the presence of saponins.
viii. Test for Terpenoids
a) Knoller’s test: 5 mg of extract is treated with 2ml of 0.1% anhydrous stannic
chloride in pure thionyl chloride.  A deep purple colour that changes to red
indicates the presence of terpenoids.
ix. Test for Proteins and Amino Acids
38
Small quantity of the extracts were dissolved in few ml of water and filtered. Filtrate
was treated with following reagent.
a) Millons reagent: It was prepared by dissolving 3 gm of mercury in 2ml of
fuming nitric acid keeping the mixture well cooled; this solution was then diluted
with equal quantity of distilled water. 2ml of residual filtrate was taken and to it,
3ml of millions reagent was added.  The white precipitate slowly turns to pink, if
proteins are present.
b) Biuret test: 1ml of filtrate was taken in water and 1ml of 4% (CuS04) copper
sulphate was added to it. Violet or pink colour is formed, if proteins are present.
c) Xanthoprotein test: A little amount of filtrate was taken in 2ml of water and
0.5ml of concentrated nitric acid was added to it.  Yellow colour is obtained if
proteins are present.
d) Ninhydrin test: The ninhydrin reagent is 0.1% w/v solution of ninhydrin in n-
butanol.  A little of this reagent was added to the test extract.  A violet or purple
colour is developed, if amino acids are present.
x. Test for Resins
a) Few mg of extract was treated with caustic soda; a red colour develops if resins
are present.
b) Few mg of extract was treated with dilute sulphuric acid; a red colour develops, if
resins are present. The results were shown in table no.5.
6.2. Toxicological Studies
6.2.1. Acute oral toxicity of Pterocarpus marsupium bark
Acute oral toxicity is performed as per OECD guide line 423. Swiss albino mice of
female sex weighing 20-25gms were used for the study. The animals were fed with
standard mouse diet, had free access to water under well ventilated condition of hours
light cycle. They were kept in metal cages with wood shavings as bedding and were
adapted to laboratory condition for 7 days prior to the experiments. The study was
carried out according to the organization for economic co-operation and Development
(OECD) principles (423) (OECD, 2001).
The animals were fasted prior to dosing according to guidelines, food but not water
was withheld for 3-4 hours. Following the period of fasting, the animals were
weighed to determine the appropriate dose of test drug to be administered to animals.
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In all the cases the maximum volume of aliquot portion of the test drug administered
did not exceed 1ml/100g of the animal body weight as per guidelines. The animals
were randomly assigned to cages for grouping and individual animals were marked
with picric acid for identification.
Three animals were used for each step: Since, there is no information on the toxicity
of the extracts to be tested, for animal welfare reasons it is decided to use the starting
dose of 5mg/kg extract suspended in CMC solution. The test extract is administered
orally to first animal and the dosing of second animal is delayed to observe the
toxicity of the previously dosed animals. Once no toxic signs were observed in
previous dosed animals, third animal is dosed. The animals were observed
individually after dosing at least once during the first 30 minutes, periodically during
the first 24 hours, with special attention given during the first 4 hours and daily
thereafter for 14 days.
 The animals dosed with 5mg/kg showed no sign of toxicity; the second step is
testing the animal with higher dose 50mg/kg. The animals were dosed
individually with 50mg/kg and observed for toxic effects.
 The second group animals showed no sign of toxic effects. The third step of
testing with 300mg/kg dose. The animals were dosed individually with
300mg/kg and observed.
 The third group animals dosed with 300mg/kg also showed no sign of toxic
effects. It is decided to increase the dose to 2000mg/kg in fourth step. The
animals were administered orally with 2000mg/kg extract suspended in CMC
& observed for toxic effects for 14 days.
 With 2000mg/kg the animals showed no sign of toxic effects; the test extract
was found to be nontoxic at 2000mg/kg.
6.2.2. Sub-acute toxicity of Pterocarpus marsupium bark
The repeat dose 28 day oral toxicity study was carried out according to OECD
guideline, 407 (OECD, 1995). A total of twenty apparently healthy mice of either sex
selected randomly into four groups were placed into four different cages (OECD,
1995).
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Group I received 10ml/kg of 0.9% saline water and served as control. Group 2, 3 and
4 received test doses of 300, 900 and 2700 mg/kg, respectively of methanol extract of
both P. marsupium. The animals were dosed daily for a period 28 days and the doses
were given at similar time each day. Adjustment was made to maintain a constant
dose level in term of animal body weight.
Animals were observed at least twice daily for morbidity and mortality. All the
animals were weighed weekly. Animals that survive after 28 days were anaesthetized
on the 29th day with chloroform and blood sample for haematological and
biochemical analysis were collected and plain vials respectively. The packed cell
volume (PCV) was determined by the microhaemocrit method. The haemoglobin
concentration (Hb) was evaluated by cyto methaemogloin method using Beckman
model of spectrophotometer. White Blood Count (WBC) and Red Blood Count
(RBC) were determined using improved Neubauer Haemocytometer. Plasma
concentration of glucose, total protein, albumin, globulin and urea were analysed
using humalyzer 2000. Necroscopy of all animals was carried out and the organ was
then standardized for percentage body weight of each mouse. Subsequently, the
animal organs harvested (the brain, liver and kidney) were fixed in 10% formalin
saline solution for histopathological examination. Thin crystal sections were stained
with haematoxylin and eosin, periodic and Schiff reagent with and without diastase,
respectively. The sections were examined under light microscope at high (400x
objective) power magnification
6.3. Pharmacological Screening
6.3.1. In-vitro anti-oxidant activity of Pterocarpus marsupium bark
The in vitro methods are based on inhibition. Samples are added to a free radical-
generating system, inhibition of the free radical action is measured and this inhibition
is related to antioxidant activity of the sample. Methods vary greatly as to the
generated radical, the reproducibility of the generation process, and the endpoint that
is used for the determination. The extract was tested for in vitro antioxidant activity
using several standard methods. The final concentration of the extract and standard
solutions used were 1000, 500, 250, 125, 62.5, 31.25 and 15.625, 7.812 g/ml. The
absorbance was measured spectrophotometrically against the corresponding blank
solution. The percentage inhibition was calculated by using the following formula.
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OD control - OD sample
Radical scavenging activity (%) = x 100
OD control
IC50, which is the concentration of the sample required to scavenge 50 % of free
radicals was calculated.
Because of the vast utility of the antioxidants in treatment of various diseases, the
following antioxidant activities were investigated on the ethanol extracts of the P.
marsupium (Sing et al., 2008; Halliwell, 1996; Jayaprakasha et al., 2004).
i) DPPH Assay: DPPH radical scavenging activity was assessed, according to the
method of Blois et al (1958). DPPH is a stable free radical with red color which turns
yellow color when scavenged.  Antioxidants react with DPPH and reduce it to DPPH-
H and as a result the absorbance decreases. The degree of discoloration indicates the
scavenging potential of the antioxidant compounds in terms of hydrogen donating
ability.
Purple color DPPH Yellow Stable phenoxy radical (2, 2-diphenyl-1-picryl hydrazyl)
is a discoloration assay, which is evaluated by the addition of the antioxidant to a
DPPH solution in ethanol or methanol and the decrease in the absorbance is measured
at 490 nm.
Procedure: The assay was carried out in a 96 well microtitre plate. To 200 μl of DPPH
solution, 10 μl of various concentrations of the extract or the standard solution was
added separately in wells of the microtitre plate. The plates were incubated at 37 ºC
for 30 min. Absorbance was measured at 517 nm using ELISA reader.
ii) Scavenging of Nitric Oxide radical: The assay was done according to the method
of Marcocci et al (1994). Sodium nitroprusside in aqueous solution at physiological
pH spontaneously generates nitric oxide, which interacts with oxygen to produce
nitrite ions, which can be estimated by the use of modified Griess Ilosvay reaction. In
NO 2N N
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NO 2
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O 2N N
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the present investigation, Griess Ilosvay reagent is modified by using naphthyl
ethylenediamine dihydrochloride (0.1% w/v) instead of 1-napthylamine (5%). Nitrite
ions react with Griess reagent, which forms a purple azo dye. In presence of test
components, likely to be scavengers, the amount of nitrites will decrease. The degree
of decrease in the formation of purple azo dye will reflect the extent of scavenging.
The absorbance of the chromophore formed was measured at 540 nm.
iii) Scavenging of 2, 2’-azino-bis (3-ethylbezothiazoline-6-sulfonic acid)
diammonium   salt) (ABTS) radical cation assay: Total antioxidant potential of
extract was determined by scavenging of 2, 2-azinobis (3-ethyl benzoline-6-sulphonic
acid) diammonium radical (ABTS) radical cation based on the procedure described by
Re et al. 1999. ABTS assay is relatively recent one, which involves a more drastic
radical, chemically produced and, is often used for screening complex antioxidant
mixture such as plant extracts, beverages and biological fluids. The solubility in both
the organic and aqueous media and the stability in a wide pH range raised the interest
in the use of ABTS radical for the estimation of the antioxidant activity.
iv) Hydroxyl radical scavenging activity:
There is increasing evidence that hydrogen peroxide, either directly or indirectly via
its reduction product hydroxyl radical (OH) causes severe damage to biological
systems. Deoxyribose assay was used to determine the hydroxyl radical scavenging
activity in an aqueous medium based on the method of Halliwell et al., (1987). This
assay is based on the quantification of the degradation product of 2-deoxyribose by
condensation with TBA. Hydroxyl radical was generated by Fe3+ ascorbate, EDTA-
H2O2 system. The reaction mixture containing FeCl3 (200µM), EDTA [1.04mM],
H2O2 (1mM)  and 2-deoxy-D-ribose (2.8mM) were mixed with or without extract at
various concentration (125-2000µg/ml) in 1mL  final reaction volume made with
potassium phosphate buffer (20mM, pH 7.4) and incubated for 1 h at 37º C. The
mixture was heated at 95ºC in water bath for 15 min followed by addition of 1mL
each of TCA (2.8%) and TBA (0.5% TBA in 0.025M NaOH containing 0.02% BHA).
Finally, the reaction mixture was cooled on ice and centrifuged at 5000rpm for 15
min. Absorbance of the supernatant liquid was measured at 532nm. The negative
control without any antioxidant or extract was considered 100% deoxyribose
oxidation. The percentage hydroxyl radical scavenging activity of test sample was
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determined accordingly in comparison with negative control. Ascorbic acid was taken
as the positive.
6.3.2 In-vitro Cytotoxicity activity of Pterocarpus marsupium bark
Cytotoxicity tests are being used for the anticancer screening of drugs. A novel
anticancer drug should possess cytotoxicity at low concentration against cancerous
cell line and should be safe against normal cell lines even at higher concentrations.
Cytotoxicity can also be monitored using the MTT or MTS assay. This assay
measures the reducing potential of the cell using a colorimetric reaction. Viable cells
will reduce the MTS reagent to a colored formazan product. Hence, the ethanol
extract of Pterocarpus marsupium bark was tested for cytotoxicity study by Micro
culture Tetrazolium (MTT) assay method (Sreejayan & Rao 1996; Halliwell &
Gutteridge 1998; Scudiero et al., 1998; Ruby et al., 1995; Francis & Rita, 1986).
Cell line and culture medium
HT-29 (Human, colorectal cancer), HeLa (Human, Epithelial cervical cancer) and
C2C12 (Mouse, Muscle cell line) cell cultures were procured from National Centre for
Cell Sciences (NCCS), Pune, India. Stock cells of  HT-29, C2C12 and HeLa were
cultured in DMEM supplemented with 10% inactivated Fetal Bovine Serum (FBS),
penicillin (100 IU/ml), streptomycin (100 g/ml) and amphotericin B (5 g/ml) in an
humidified atmosphere of 5% CO2 at 37C until confluent. The cells were dissociated
with TPVG solution (0.2% trypsin, 0.02% EDTA, 0.05% glucose in PBS). The
stockcultures were grown in 25 cm2 culture flasks and all experiments were carried
out in either 96 microtitre plates.
Preparation of test solutions
For cytotoxicity studies, each weighed extracts and essential oils were separately
dissolved in distilled DMSO and volume was made up with DMEM supplemented
with 2% inactivated FBS to obtain a stock solution of 1mg/ml concentration and
sterilized by filtration. Serial two fold dilutions were prepared from this for carrying
out cytotoxic studies.
Determination of cell viability by MTT assay
The ability of the cells to survive a toxic insult has been the basis of most cytotoxicity
assays. This assay is based on the assumption that dead cells or their products do not
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reduce tetrazolium. The assay depends both on the number of cells present and on the
mitochondrial activity per cell. The principle involved is the cleavage of tetrazolium
salt 3-(4,5-dimethyl thiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) into a
blue coloured product (formazan) by mitochondrial enzyme succinate dehydrogenase.
The number of cells was found to be proportional to the extent of formazan
production by the cells used.
Procedure: The monolayer cell culture was trypsinized and the cell count was
adjusted to 1.0x105 cells/ml using DMEM medium containing 10% FBS/NBCS. To
each well of the 96 well microtitre plate, 0.1ml of the diluted cell suspension
(approximately 10,000 cells) was added. After 24 h, when a partial monolayer was
formed, the supernatant was flicked off, washed the monolayer once with medium and
100l of different test concentrations were added on to the partial monolayer in
microtitre plates. The plates were then incubated at 37o C for 3 days in 5% CO2
atmosphere, and microscopic examination was carried out and observations were
noted every 24 h interval. After 72 h, the extract solutions in the wells were discarded
and 50l of MTT in PBS was added to each well. The plates were gently shaken and
incubated for 3 h at 37o C in 5% CO2 atmosphere. The supernatant was removed and
100l of propanol was added and the plates were gently shaken to solubilize the
formed formazan. The absorbance was measured using a microplate reader at a
wavelength of 540 nm. The percentage growth inhibition was calculated using the
following formula and concentration of drug or test extract needed to inhibit cell
growth by 50 % (CTC50) values is generated from the dose-response curves for each
cell line (Senthilkumar et al., 2007; Santhoskumar et al., 2007; Vijayan et al., 2003).



 100100% X
groupcontrolofODMean
grouptestindividualofODMeanInhibitionGrowth
6.4 Statistical Analysis
The experimental results were expressed as the mean ± S.E.M. Data were assessed by
the method of analysis of ANOVA, followed by Dunnet’s t-test; p value of < 0.05 was
considered as statistically significant.
45
5. RESULTS AND DISCUSSION
5.1. Phytochemical studies
5.1.1. Extraction
Preliminary Phytochemical studies on ethanol extracts of P. marsupium bark
Table No.4 Data showing the extractive value of ethanol extract of Pterocarpus
marsupium bark
Plant Name Parts
used Method used
Solvent Used %w/w yield
Using
Pterocarpus
marsupium Leaves
Continuous hot
percolation process
Ethanol
(95 % v/v) 7.06
Table No. 5 Data showing the preliminary phytochemical screening of the
ethanol extracts of the Pterocarpus marsupium bark
Sl.
No Phytoconstituents P. marsupium
1. Carbohydrates +
2. Glycosides +
3. Alkaloids -
4.
Phytosterol and
steroids +
5. Flavonoids +
6. Proteins&AminoAcids. +
7. Tannins -
8. Resins -
9. Gums and mucilages -
10. Triterpenoids +
+ Present; -Absent
RESULT
The dried powder materials of bark of P. marsupium were extracted with ethanol in a
Soxhlet apparatus. The yield was 7.06 % w/w. The tested ethanol extracts of P.
marsupium showed the presence of phytoconstituents such as carbohydrates, sterols,
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glycosides, phytosterols and steroids, proteins & amino acids, flavonoids and
triterpenoids. The results are shown in Table No.4 and 5.
5.2. Toxicological Studies
5.2.1. Acute oral toxicity of Pterocarpus marsupium bark
Acute oral toxicity was performed as per OECD guide line 423
Table No.10 Acute oral toxicity study (423) observations
Respiratory Blockage Innostril
Dyspnoea Nil
Apnoea Nil
Tachypnea Nil
Nostril discharge Nil
Motor Activities
Locomotion Normal
Somnolence Nil
Loss of righting reflex Nil
Anaesthesia Nil
Catalepsy Nil
Ataxia Nil
Toe walking Nil
Prostration Nil
Fasciculation Nil
Tremor Nil
Convulsion (Involuntary Contraction)
clonic/tonic/tonic-clonic convulsion Nil
Asphyxia convulsion Nil
Opistotones (titanic spasm) Nil
RESULT AND DISCUSSION
The acute oral toxicity study of methanol extracts of P. marsupium was determined as
per the OECD guidelines 423 (Acute toxic class method). The animals were observed
for 14 days period for any signs of delayed toxicity. Both the extracts have good
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margin of safety. The extracts did not show lethal effect on albino mice up to the dose
of 2000mg/kg. Hence, submaximal doses, 1/10th (200mg /kg) and 1/20th (100mg/kg)
of maximum dose were selected for study.
Table No. 12 Mean body weight of mice after 28 days treatment with EEPM
bark
Data are mean ± SEM; n=5 A ANOVA; *P < 0.05; **P < 0.01; ***P < 0.001
ns: non-significant (between control and experimental group)
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Control 300 EEPM 900 EEPM 2700 EEPM
Treatment
and Dose
mg/kg
Day 1 Day 7 Day 14 Day 21 Day28
Mean
wt.
gain
Control 25.09 ±1.14 25.85±0.15 26.25±1.21 27.41±0.45 28.51±0.12 3.06
300
EEPM 24.90±025
ns 25.12±0.12ns 26.61±0.45ns 27.54±0.13ns 28.52±0.58ns 3.65
900
EEPM 22.59±0.11
ns 23.69±0.21ns 24.36±0.65ns 25.16±0.15ns 26.12±0.65ns 3.87
2700
EEPM 23.56±0.26
ns 24.21±0.15ns 25.15±0.14ns 26.12±0.26\ns 27.36±0.18ns 3.9
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Table No. 13 Haematological parameters of mice after 28 days treatment with
EEPM bark
Data are mean ± SEM; n=5 A ANOVA; *P < 0.05; **P < 0.01; ***P < 0.001
ns: non-significant (between control and experimental group)
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RBC(x106L-1 ) Hb (g/ L-1) PCV (%) WBC (%)
Treatment
and Dose
mg/kg
RBC(x106L-1 ) Hb (g/ L-1) PCV (%) WBC (%)
Control 4.18±0.22 7.19±0.25 21.11±0.52 4.71±1.28
300
EEPM 3.57±0.56
ns 6.55±1.5 ns 23.15±0.11 ns 4.15±0.17 ns
900
EEPM 4.11±0.12
ns 6.69±0.21 ns 20.52±0.62 ns 3.53±0.61 ns
2700
EEPM 3.88±0.15
ns 6.08±0.14 ns 22.16±0.98 ns 4.15±0.31 ns
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Table No. 14 Leucocytes differential count of mice after 28 days treatment
EEPM bark
Data are mean ± SEM; n=5 A ANOVA; *P < 0.05; **P < 0.01; ***P < 0.001
ns: non-significant (between control and experimental group)
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Control 300 EEPM 900 EEPM 2700 EEPM
Treatment
and Dose
mg/kg
Neutrophils
(%)
Eosinophils
(%)
Monocytes
(%)
Lymphocytes
(%)
Basophils
(%)
Control 33.54 ±3.05 2.2±1.05 6.05±1.25 59.85±7.6 0.00
300
EEPM 32.59±2.35
ns 2.5±0.71 ns 6.58±0.35 ns 58.45±2.15 ns 0.00
900
EEPM 35.66±1.67
ns 2.5±0.16 ns 7.5±0.57 ns 56.68±2.85 ns 0.00
2700
EEPM 32.98±2.56
ns 2.6±1.12 ns 6.88±0.14 ns 59.58±0.48 ns 0.00
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RESULT AND DISCUSSION
From the sub-acute toxicity studies of EEPM, it was observed that there was no
significant difference in the mean organ weight between the control and the animals
treated with the EEPM (Table No. 11). Similarly, there was also no significant
difference in the  mean body weight between control and the animals treated with
EEPM (Table No.12).
Haematological analysis showed no significant difference in RBC, Hb, PCV and
WBC between control and extract treated groups (Table No.13). The leukocyte
differential count between control and extract treated group were also non-significant
(Table- 14)
The results of biochemical study also showed no significant difference between the
control and the animals treated with the extracts in all the biochemical parameters
tested. Observation for gross pathological lesions of the organs examined immediately
after dissection showed no visible lesion.
Histopathological examination of liver, kidney and the brain in the control and the
animals treated with the extracts showed no lesion that could be attributed to the
effect of oral administration of EEPM on mice for 28 days.
The sub-acute toxicity findings therefore indicate that the extracts appeared to have
low toxicity and could be as well tolerated for the 28 days study period.
The observations of both acute and sub-acute toxicity could be an indication that
EEPM has some high level of safety margin in oral administration.
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5.3. Pharmacological Screening
4.3.1 In vitro Antioxidant Activity of EEPM bark
Table No.15 In vitro DPPH antioxidant activity of EEPM bark
DPPH
IC50 values ± SEM g/ml* by methods
Sl:No Con g/ml
Percentage inhibition
Standard
Ascorbic
acid
EEPM
1 10 45 40
2 20 48 44
3 40 56 49
4 80 67 55
5 160 88 67
IC50 value 27.43 57.03
*Average of three determinations, values are mean ± SEM
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Table No.15 In vitro nitric oxide antioxidant activity of EEPM bark
Nitric oxide
IC50 values ± SEM g/ml* by methods
Sl:No Con g/ml
Percentage inhibition
Standard
Rutin EEPM
1 10 46 23
2 20 52 28
3 40 58 40
4 80 67 64
5 160 89 82
IC50 value 22.76 59.13
*Average of three determinations, values are mean ± SEM
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Table No.15 In vitro ABTS antioxidant activity of EEPM bark
ABTS
IC50 values ± SEM g/ml* by methods
Sl:No Con g/ml Percentage inhibition
Standard
Rutin
EEPM
1 10 41 12
2 20 54 20
3 40 65 36
4 80 81 63
5 160 92 75
IC50 value 16.23 61.62
*Average of three determinations, values are mean ± SEM
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Table No.15 In vitro AH2O2 antioxidant activity of EEPM bark
H2O2
IC50 values ± SEM g/ml* by methods
Sl:No Con g/ml Percentage inhibition
Standard
Ascorbic
acid
EEPM
1 10 48 23
2 20 64 39
3 40 76 48
4 80 88 59
5 100 95 72
IC50 value 10.85 44.76
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Result
The EEPM exhibited potent DPPH and ABTS radical scavenging activity with IC50
values 16.56 ± 0.88 and 39.00 ± 1.31g/ml, respectively. MEAV showed good
antioxidant activity against H2O2 radical with IC50 values 97.80 ± 4.55 g/ml which
showed better activity than standard Ascorbic acid and moderate antioxidant activity
against nitric oxide radical with IC50 value 345.50 ± 11.00 g/ml respectively.
Discussion
The free radical scavenging activity of natural compounds can be evaluated through
their ability to quench the synthetic free radicals,  in  which  the  absorbance  of  the
reaction  mixture  is  taken in  visible  range  to  know whether the  compound  is
having  antioxidant  property (Halliwell & Gutteridge 1998). The above observations
reveal that the drug has considerable antioxidant activity. The EEPM produced
significant % inhibition in the levels against ABTS radical scavenging activity, but
moderate antioxidant activity against nitric oxide, DPPH and H2O2 radicals
respectively.
4.3.2 In Vitro cytotoxicity activity of ethanol extracts of Pterocarpus marsupium
bark
Table No.17 Cytotoxicity activity of EEPM bark on different cell lines.
Extract Cell line Test Concentrations( µg/ml) %Cytotoxicity CTC50 (µg/ml)
EEPM HT-29
1000
500
250
125
62.5
31.25
71.85
41.56
35.65
24.74
10.65
0.00
485.64
EEPM HeLa
1000
500
250
125
62.5
31.25
66.54
37.75
22.87
14.19
5.54
0.00
625.90
EEPM C2C12
1000
500
250
125
62.5
31.25
51.07
43.53
28.57
17.06
0.00
0.00
> 1000
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Result
The EEPM exhibited moderate cytotoxic properties towards cancerous cell lines HT-
29 and HeLa with CTC50 values 701.50 and 785.50μg/ml, respectively. Whereas
against C2C12, test extract failed to exhibit cytotoxicity at test concentrations with
only 32% cytotoxicity at 1000μg/ml.
Discussion
Treating cells with a cytotoxic compound can result in a variety of cell fates. The cells
may undergo necrosis, in which they lose membrane integrity and die rapidly as a
result of cell lysis. The cells can stop actively growing and dividing (a decrease in cell
viability), or the cells can activate a genetic program of controlled cell death
(apoptosis).With regard to the possible anticancer mechanisms involved, flavonoids
have been reported to exhibit their anticancer activity via the modulation of cell cycle
arrest at the G1/S phase, down-regulation of anti-apoptotic gene products (Vijayan et
al., 2003). On other hand, saponins induce anticancer activity via the necrosis cell
death, which depends on the types of cancer cells affected (Dymock Indica, 1995).
0
10
20
30
40
50
60
70
80
31.25 62.5 125 250 500 1000
Pe
rc
en
ta
ge
Test concentrations in mcg/ml
HT-29 HeLa C2C12
57
Furthermore, triterpenoids also induce apoptotic response on cancer cells by
inhibiting nuclear factor-kappa B or by causing cell cycle disruption (by decreasing
the number of cells in G0/G1 phase with initial increase in S and G2/M) (Sivakumar
et al., 2005). In conclusion, EEPM was found to possess moderate cytotoxicity
activity against the HT-29 and HeLa cell lines, which could be associated with its
antioxidant mechanisms.
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6. SUMMARY AND CONCLUSION
The present dissertation work was carried out to evaluate the in vitro antioxidant and
in vitro anticancer activities of ethanol extract of Pterocarpus marsupium ROXB.
bark.
Literature survey revealed that P. marsupium is a versatile medicinal plant and is a
unique source of wide range of phytocompounds with diverse chemical structure and
pharmacological activity. Very little work has been reported thus far on the biological
activity and plausible medicinal applications of these compounds and hence extensive
investigation is needed to exploit their therapeutic utility to combat diseases. The
plant has been widely studied for its pharmacological activities for antidiabetic
activities and regarded as universal panacea in Ayurvedic medicines and is believed to
be a versatile plant having a wide spectrum of medicinal activities. With the
application of proper scientific and technological advances, a logical interpretation of
the codified language of traditional medicine has become a necessity to further
promote drug discovery and drug development. Efforts have to be explored and
studies need to be undertaken to isolate and develop new molecules especially, with
the compounds isolated from P. marsupium. Although crude extracts from various
parts of P. marsupium have been reported to be used as medicinal applications from
time immemorial, modern drugs can be further refined and developed after extensive
investigation of its bioactivity, mechanism of action, pharmacotherapeutics, and
toxicity and after proper standardization and clinical trials.
P. marsupium bark was extracted with ethanol and the yield was 7.06 % w/w. The
chemical constituents of the extract were identified by qualitative analysis.
Preliminary phytochemical analysis of P. marsupium showed the positive test of as
carbohydrates, sterols, glycosides, phenols, phytosterols and steroids, proteins&
amino acids, flavonoids, triterpenoids.
The acute and sub-acute toxicity study of P. marsupium did not show any toxic signs
at different increasing dosage levels upto 2000mg for acute and 2700mg for subacute
levels.  From the results, it was observed that both plant extracts were safe for oral
administration on study conducted in mice.
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In in vitro antioxidant activity, EEPM exhibited potent DPPH and ABTS radical
scavenging activity and showed good antioxidant activity against H2O2 radical,
showed better activity than standard Ascorbic acid and moderate antioxidant activity
against nitric oxide radical.
In vitro cytotoxicity activity of EEPM revealed that it exhibited moderate cytotoxic
properties towards cancerous cell lines HT-29 and HeLa, whereas against C2C12, test
extract failed to exhibit cytotoxicity at test concentrations with only 32 % cytotoxicity
at 1000 μg/ml.
As the global scenario is now changing towards the use of non-toxic plant products
having traditional medicinal use, development of modern drugs from P. marsupium
should be emphasized for the control of various diseases. In fact, time has come to
make good use of centuries-old knowledge on P. marsupium through modern
approaches of drug development. For the last few years, there has been an increasing
trend and awareness in P. marsupium research. Quite a significant amount of research
has already been carried out during the past few decades in exploring the chemistry of
different parts of P. marsupium. Several therapeutically and industrially useful
preparations and compounds have also been marketed, which generates enough
encouragement among the scientists in exploring more information about this
medicinal plant. An extensive research and development work should be undertaken
on P. marsupium and its products for their better economic and therapeutic utilization.
In may be concluded that the in vitro antioxidant and in vitro anticancer activities and
other associated biodynamic pharmacological activities of the ethanol extract of P.
marsupium may be attributed to the presence of triterpenoids and flavonoids and other
phytoconsitutents in the extract. However, further studies are needed to isolate the
phytoconsitutents and to explore the pharmacological actions of the isolated
compounds and the mode of action of these terpenoids and flavonoids and other
phytochemicals.
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